Dishman Carbogen Amcis Hits 52-Week High, Showcasing Strong Performance in Pharma Industry
Dishman Carbogen Amcis Ltd, a smallcap pharmaceutical company, has reached a 52-week high with its stock price hitting Rs.282.95 on March 5th, 2024. The stock is currently trading higher than its moving averages and has shown a strong performance in the past year, indicating potential for growth in the pharmaceutical industry.
Dishman Carbogen Amcis Ltd, a smallcap pharmaceutical company, has recently hit a 52-week high with its stock price reaching Rs.282.95 on March 5th, 2024. This comes after four consecutive days of gains for the company's stock.
According to MarketsMOJO, a leading stock analysis and recommendation platform, the stock call for Dishman Carbogen Amcis is currently 'Sell'. However, the company's performance today is in line with the overall sector.
The stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend for the company.
In the past year, Dishman Carbogen Amcis has shown a strong performance with a growth of 126.84%, outperforming the Sensex's performance of 23.06%. This showcases the company's potential for growth and success in the pharmaceutical industry.
Dishman Carbogen Amcis is a smallcap company in the pharma industry, with a focus on providing high-quality and cost-effective solutions for drug development and manufacturing. With its recent 52-week high, the company is poised for further growth and success in the market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
